Dietary Acrylamide Intake and Risk of Esophageal, Gastric, and Colorectal Cancer: The Japan Public Health Center–Based Prospective Study

Abstract

Background: Acrylamide has been classified as a probable human carcinogen based chiefly on laboratory evidence. However, the influence of dietary acrylamide intake on risk of esophageal, gastric, and colorectal cancer has not been extensively studied. We aimed to evaluate the association between dietary acrylamide intake and esophageal, gastric, and colorectal cancer using data from the Japan Public Health Center-based Prospective Study. Methods: Our study included 87,628 participants who completed a food-frequency questionnaire at enrollment in 1990 and 1993. We used Cox proportional hazards regression models to estimate hazards ratios and 95% confidence intervals (CI) after adjusting for confounding factors. Results: After 15.5, 15.3, and 15.3 mean years of follow-up for esophageal, gastric, and colorectal cancer, we identified and analyzed 391 esophageal, 2,218 gastric, and 2,470 colo-rectal cancer cases, respectively. Compared with the lowest quintile of acrylamide intake, the multivariate HR for the highest quintile was 0.86 (95% CI, 0.53-1.39; P trend ¼ 0.814), 0.84 (95% CI, 0.69-1.01; P trend ¼ 0.301), and 0.93 (95% CI, 0.79-1.08; P trend ¼ 0.165) for esophageal, gastric, and colorectal cancer, respectively, in the multivariableadjusted model. Furthermore, no significant associations were observed when the participants were stratified by cancer subsites. Conclusions: In conclusion, this study demonstrated that dietary acrylamide intake was not associated with increased risk of esophageal, gastric, or colorectal cancer among the Japanese population. Impact: It is the first time to assess the effect of dietary acrylamide intake on risk of digestive system cancer in Asian populations.

Dietary Acrylamide Intake and the Risk of Liver Cancer: The Japan Public Health Center-Based Prospective Study

“…Participants were asked to report the general average consumption frequency of 138 food and beverage items, of standard portion size, in the last year [14]. The details of response choices for frequency, standard portion size, and relative portion sizes have been described elsewhere [15][16][17]. The validity and reproducibility study of the FFQ has been conducted by taking the dietary intakes from 28-day weighed dietary records (DRs) as a reference in a subcohort of the JPHC Study [18][19][20].…”

ERas Enhances Resistance to Cisplatin-Induced Apoptosis by Suppressing Autophagy in Gastric Cancer Cell

“…Gastric cancer is one of the most common cancers worldwide, especially in Asia, with only a 5 year survival rate of diagnosis (Liu et al, 2019;Rugge et al, 2019). Despite developments in the treatment of GC, the prognosis remains poor.…”

Notoginsenoside R1 Protects Against the Acrylamide-Induced Neurotoxicity via Upregulating Trx-1-Mediated ITGAV Expression: Involvement of Autophagy

“…According to laboratory evidence, ACR has been classified as a possible human carcinogen. It has also been proved that dietary acrylamide intake causes esophageal, gastric, and colorectal cancer ( Liu R. et al, 2019 ). Besides, lots of studies have proved that neurotoxicity of acrylamide in tissues and organs has been confirmed at the animal levels ( Song et al, 2008 ; Tomaszewska et al, 2014 ).…”